Sun's generic venlafaxine faces significant delay in the US
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industriesfaces a significant delay in its launch plans for generic venlafaxine extended-release tablets 37.5mg, 75mg and 150mg, after the US FDAgranted Osmotica Pharmaceutical's Citizen Petition on the product.